Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021

Dear Editor,

Source: Journal of Infection - April 24, 2023 Category: Infectious Diseases Authors: Yu-Lin Lee, Po-Ren Hsueh Source Type: research